F/M Emr Life Sciences in ETFLFSCETF
13F holders, Q1 2026 (March 31)7holders
3new positions
3sold out
$34.98avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding F/M Emr Life Sciences in ETF (LFSC) in their 13F filings, unchanged from Q4 2025. 3 opened new positions and 3 sold out. The largest holders were Emerald Mutual Fund Advisers Trust ($69.9M), Sbe LLC Dba Cedar Cove Wealth Partners ($2.4M) and Hunter Associates Investment Management LLC ($1.7M).
- Company
- F/M Emr Life Sciences in ETF
- Filed as
- RBB FD INC (Q1 2026)
- CUSIP
- 74933W221
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3.2M |
| Exits | 3 | $10.2M |
All 13F filers, Q4 2025 → Q1 2026: 99,224 shares bought and 279,331 shares sold, net −180,107 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Emerald Mutual Fund Advisers Trust | 3.39% | No change | 1,997,035 | $69.9M |
| Sbe LLC Dba Cedar Cove Wealth Partners | 1.28% | New | 69,994 | $2.4M |
| Hunter Associates Investment Management LLC | 0.23% | Add +8.3% | 49,739 | $1.7M |
| Atria Investments, Inc | 0.01% | New | 22,345 | $782K |
| Tidal Investments LLC | 0.00% | Add +17.4% | 19,958 | $698K |
| Advisory Services Network, LLC | 0.00% | New | 100 | $3K |
| UBS Group AG | 0.00% | Reduce -93.9% | 21 | $735 |
"% of holder's portfolio" is LFSC's weight in each manager's 13F, not the share of F/M Emr Life Sciences in ETF the manager owns.